UNSPSC 51283407: Pheneticillin or phenethicillin

This classification denotes a penicillin v analog and anti-bacterial agent with the molecular formula C17H20N2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EFA30X554H, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxypropionamido)- but generally known as pheneticillin, which bears US NIH Compound Identifier 4759. European Medicines Agency schedules Pheneticillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09759MIG.

World Health Organization schedules pheneticillin in its Anatomical Therapeutic Chemical (ATC) Classification. PHENETICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C2N(C(C1(C)C)C(=O)O)C(=O)C2NC(=O)C(OC1CCCCC1)C.

UNSPSC 51283407 Pheneticillin or phenethicillin is a Commodity code that nominally addresses a specific penicillin-derivative antibiotic; however, recent state and local procurement activity under this code shows little alignment with the code's stated scope. The two opportunities tagged to the code involve pharmaceutical procurement more broadly — one addressing doxycycline and ciprofloxacin supply through a cooperative purchasing piggyback contract, the other covering naloxone and drug deactivation systems for community health. State and local health departments and counties are the issuing bodies, but the actual goods being procured diverge significantly from the narrow pharmaceutical classification the code implies.

Recent activity centers on Illinois and Florida. The Illinois Department of Public Health completed an award to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride through the MMCAP Infuse consortium piggyback vehicle, with a total contract value of $2,999,999.11 over the full term including renewals; this was an Invitation for Bid process. Seminole County, Florida issued an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, though the due date in the source appears superseded (July 26, 2023, is inconsistent with the June 2026 posting date). The code shows limited recent relevant procurement velocity, and the opportunities posted under it appear misclassified relative to the pharmaceutical category intended by the UNSPSC designation.